Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 7/2005

01-07-2005 | Original Article

Apoptosis and production of TNF-α by tumor-associated inflammatory cells in histological grade III breast cancer

Authors: Farias Rogério Estevam, Soares Fernando Augusto, Souza Andrezza Rodrigues, Machado Raquel Rocha Pinheiro, Aarestrup Fernando Monteiro

Published in: Cancer Immunology, Immunotherapy | Issue 7/2005

Login to get access

Abstract

Tumor necrosis factor alpha (TNF-α) is a cytokine that acts as an important mediator of the apoptotic process that also demonstrates selective citotoxicity against malignant breast tumor cells. In the present study, the presence of apoptotic tumor cells and the synthesis of TNF-α by inflammatory cells were investigated in tissue samples from grade III invasive breast cancer with long-term follow-up. In situ detection of tumor apoptotic cells was investigated by direct immuno-peroxidase of digoxigenin-labeled genomic DNA. The production of TNF-α and tumor cell proliferation were investigated by immunohistochemical procedures. Our data demonstrated that patients with a clinical history of cancer recurrence and metastasis presented a lower number of cancerous apoptotic cells, higher tumor proliferation rates, and lower TNF-α expression rates by inflammatory cells than what is observed among patients diagnosed with the same histopathological breast cancer type but in the absence of tumor recurrence and metastasis.
Literature
1.
go back to reference Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego MS, Grassi MG, Pittalis S, Crispino S, Barni S, Tancini G (1992) Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Reg Hom Agentes 6:103–107 Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego MS, Grassi MG, Pittalis S, Crispino S, Barni S, Tancini G (1992) Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Reg Hom Agentes 6:103–107
2.
go back to reference Basu A, Mohanty S, Sun B (2001) Differential sensitivity of breast cells to tumor necrosis factor-α: involvement of protein kinase C. Bioch Biophy Res Commu 280:883–891CrossRef Basu A, Mohanty S, Sun B (2001) Differential sensitivity of breast cells to tumor necrosis factor-α: involvement of protein kinase C. Bioch Biophy Res Commu 280:883–891CrossRef
3.
go back to reference Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 were followed for 15 years. Br J Cancer11:359–377 Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 were followed for 15 years. Br J Cancer11:359–377
4.
go back to reference Bower JE, Ganz PA, Aziz N, Fahey JL (2002) Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64:604–611 Bower JE, Ganz PA, Aziz N, Fahey JL (2002) Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64:604–611
5.
go back to reference Caras I, Grigorescu A, Stavaru C, Radu DL, Mogos I, Szegli G, Salageanu A (2004) Evidence of immune defects in breast and lung cancer patients. Cancer Immunol Immunother. Epub Caras I, Grigorescu A, Stavaru C, Radu DL, Mogos I, Szegli G, Salageanu A (2004) Evidence of immune defects in breast and lung cancer patients. Cancer Immunol Immunother. Epub
6.
go back to reference Chopin V, Slomianny C, Hondermarck H, Le Bourhis X (2004) Synergistic induction of apoptosis in breast cancer cells by co-treatment with butyrate and TNF-alfa, TRAIL, or antibody involves enhancement of death receptor signaling and requires P21(waf1). Exp Cell Res 298(2):569–73CrossRef Chopin V, Slomianny C, Hondermarck H, Le Bourhis X (2004) Synergistic induction of apoptosis in breast cancer cells by co-treatment with butyrate and TNF-alfa, TRAIL, or antibody involves enhancement of death receptor signaling and requires P21(waf1). Exp Cell Res 298(2):569–73CrossRef
7.
go back to reference Christopher Weldon B, Matthew Burow E, Kevin Rolfe W, John Clayton L, Bernard Jaffe M, Barbara Beckman S (2001) NF-κB-mediated chemoresistance in breast cancer cells. Surgery 130:143–150CrossRef Christopher Weldon B, Matthew Burow E, Kevin Rolfe W, John Clayton L, Bernard Jaffe M, Barbara Beckman S (2001) NF-κB-mediated chemoresistance in breast cancer cells. Surgery 130:143–150CrossRef
8.
go back to reference Cuello M, Ettenberg, Amy Clarrk S, Maccon Keane M, Reuben Posner H, Marion Nau M, Philip Dennis A, Stan Lipkowitz (2001) Down-regulation of the erbB-2 receptor by trastuzumab (Herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res 61:4892–4900 Cuello M, Ettenberg, Amy Clarrk S, Maccon Keane M, Reuben Posner H, Marion Nau M, Philip Dennis A, Stan Lipkowitz (2001) Down-regulation of the erbB-2 receptor by trastuzumab (Herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res 61:4892–4900
9.
go back to reference De Jong JS, Van Diest PJ, Baak JP (2000) Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br J cancer 82:368–373CrossRef De Jong JS, Van Diest PJ, Baak JP (2000) Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br J cancer 82:368–373CrossRef
10.
go back to reference Deregowski Valérie, Delhalle Silvie, Benoit Valérie, Bours Vincent, Merville Marie-Paule (2002) Identification of cytokine-induced nuclear factor-kappa B target genes in ovarian and breast cancer cells. Bioch Pharm 64:873–881CrossRef Deregowski Valérie, Delhalle Silvie, Benoit Valérie, Bours Vincent, Merville Marie-Paule (2002) Identification of cytokine-induced nuclear factor-kappa B target genes in ovarian and breast cancer cells. Bioch Pharm 64:873–881CrossRef
11.
go back to reference Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer I. The value of histological grades in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19:403–410PubMed Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer I. The value of histological grades in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19:403–410PubMed
12.
go back to reference Fujiki H, Suganuma M, Okabe S, Kurursu M, Imai K, Nakachi K (2002) Involvement of TNF-alpha changes in human cancer development, prevention and palliative care. Mech Ageing Dev 123:1655–1663CrossRef Fujiki H, Suganuma M, Okabe S, Kurursu M, Imai K, Nakachi K (2002) Involvement of TNF-alpha changes in human cancer development, prevention and palliative care. Mech Ageing Dev 123:1655–1663CrossRef
13.
go back to reference Gandhi A, Holland PA, Knox WF, Poten CS, Bundred NJ (1998) Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast. Br J Cancer 78:788–794 Gandhi A, Holland PA, Knox WF, Poten CS, Bundred NJ (1998) Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast. Br J Cancer 78:788–794
14.
go back to reference González-Cámpora R, Ruiz MRG, Ramirez FV, Martin JJR, Santos JMF, Martos MMR, Pascual AG (2000) Apoptosis in breast cancer. Pathol Res Pract 196:167–174 González-Cámpora R, Ruiz MRG, Ramirez FV, Martin JJR, Santos JMF, Martos MMR, Pascual AG (2000) Apoptosis in breast cancer. Pathol Res Pract 196:167–174
15.
go back to reference Hagemann T, Robison SC, Schulz M, Trumper L, Balkwill FR, Blinder C (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-{alfa}- dependent up-regulation of matrix metalloproteases. Carcinogenesis 25(8):1543–1549CrossRef Hagemann T, Robison SC, Schulz M, Trumper L, Balkwill FR, Blinder C (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-{alfa}- dependent up-regulation of matrix metalloproteases. Carcinogenesis 25(8):1543–1549CrossRef
16.
go back to reference Kataki A, Scheid P, Piet M, Marie B, Martinet N, Martinet Y, Vignaud JM (2002) Tumor infiltrant limphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab clin Med 140:320–328CrossRef Kataki A, Scheid P, Piet M, Marie B, Martinet N, Martinet Y, Vignaud JM (2002) Tumor infiltrant limphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab clin Med 140:320–328CrossRef
17.
go back to reference Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY, Jeong S (2003) Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor or TNF-related apoptosis-inducing ligand in human cancer cell lines. Cancer Res 63:621–626 Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY, Jeong S (2003) Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor or TNF-related apoptosis-inducing ligand in human cancer cell lines. Cancer Res 63:621–626
18.
go back to reference Korobko EV, Saschenco LP, Prockhorchouk EB, Korobko IV, Gnuchev NV, Kiselev SL (1999) Resistance to tumor necrosis factor-induced apoptosis in vitro correlates with high metastatic capacity of cells in vivo. Immunol Lett 67:71–76CrossRef Korobko EV, Saschenco LP, Prockhorchouk EB, Korobko IV, Gnuchev NV, Kiselev SL (1999) Resistance to tumor necrosis factor-induced apoptosis in vitro correlates with high metastatic capacity of cells in vivo. Immunol Lett 67:71–76CrossRef
19.
go back to reference Nishimura R, Nagao K, Myayama H, Matsuda M, Baba K, Matsuoka Y, Yamashita H, Fukuda M, Higuchi A (1999) Apoptosis in breast cancer and its relationship to clinicopathological characteristics and prognosis. J surg Oncol 71:226–234 Nishimura R, Nagao K, Myayama H, Matsuda M, Baba K, Matsuoka Y, Yamashita H, Fukuda M, Higuchi A (1999) Apoptosis in breast cancer and its relationship to clinicopathological characteristics and prognosis. J surg Oncol 71:226–234
20.
go back to reference Park KS, Mok JW, Ko HE,Tokunaga K, Lee MH (2002) Polymorphism of tumor necrosis factors A and B in breast cancer. Eur J Immunogenet 29:7–10CrossRef Park KS, Mok JW, Ko HE,Tokunaga K, Lee MH (2002) Polymorphism of tumor necrosis factors A and B in breast cancer. Eur J Immunogenet 29:7–10CrossRef
21.
go back to reference RamaKrishnan R, Werbeck J, Khurana KK, Khan AS (2003) Expression of interleukin-6 and tumor necrosis alpha and histopathologic findings in painful and nonpainful breast tissue. Breast J 9:91–97CrossRef RamaKrishnan R, Werbeck J, Khurana KK, Khan AS (2003) Expression of interleukin-6 and tumor necrosis alpha and histopathologic findings in painful and nonpainful breast tissue. Breast J 9:91–97CrossRef
22.
go back to reference Sabel MS, Skitzki J, Stoolman L, Egilmez NK, Mathiowitz E, Bailey N, Chang WJ, Chang AE (2004) Intratumoral IL-12 and TNF-alfa-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity. Ann Surg Oncol 11(2):147–156CrossRef Sabel MS, Skitzki J, Stoolman L, Egilmez NK, Mathiowitz E, Bailey N, Chang WJ, Chang AE (2004) Intratumoral IL-12 and TNF-alfa-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity. Ann Surg Oncol 11(2):147–156CrossRef
23.
go back to reference See D, Mason S, Roshan R (2002) Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunol Invest 31:137–153CrossRef See D, Mason S, Roshan R (2002) Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunol Invest 31:137–153CrossRef
24.
go back to reference Shen WH, Zhou JH, Broussard SR, Freund GG, Dantzer R, Kelley KW (2002) Pro-inflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. Cancer Res 62:4746–4756 Shen WH, Zhou JH, Broussard SR, Freund GG, Dantzer R, Kelley KW (2002) Pro-inflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. Cancer Res 62:4746–4756
25.
go back to reference Simiantonaki N, Jayasinghe C, Kirkpatrick CJ (2002) Effect of pro-inflammatory stimuli on tumor cell-mediated induction of endothelial cell adhesion molecules in vitro. Exp Mol Pathol 73:46–53CrossRef Simiantonaki N, Jayasinghe C, Kirkpatrick CJ (2002) Effect of pro-inflammatory stimuli on tumor cell-mediated induction of endothelial cell adhesion molecules in vitro. Exp Mol Pathol 73:46–53CrossRef
Metadata
Title
Apoptosis and production of TNF-α by tumor-associated inflammatory cells in histological grade III breast cancer
Authors
Farias Rogério Estevam
Soares Fernando Augusto
Souza Andrezza Rodrigues
Machado Raquel Rocha Pinheiro
Aarestrup Fernando Monteiro
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 7/2005
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-004-0639-0

Other articles of this Issue 7/2005

Cancer Immunology, Immunotherapy 7/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine